JPRN-UMIN000016206RecruitingPhase 1
A phase I/II clinical trial of radical radiotherapy using proton for early breast cancer - A phase I/II clinical trial of radical radiotherapy using proton for early breast cancer
Fukui Prefectural Hospital0 sites20 target enrollmentStarted: January 13, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 50years-old to ot applicable (—)
- Sex
- Female
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.Severe complication 2.Previous treatment 3.Active double primary 4.Tumor invasion to skin or chest wall 5.Distance between tumor border to skin less than 1cm on MRI. 6.Previous irradiation at tumor site 7. Non invasive ductal carcinoma (pure DCIS) 8. Medically, psychologically or other reason who are not suitable for candidate. 9. History of connective tissue diseases
Investigators
Similar Trials
Recruiting
Not Applicable
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancerbreast cancerJPRN-UMIN000029478QST Hospital, National Institutes for Quantum and Radiological Sciences and Technology30
Recruiting
Phase 1
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancerD001943Breast cancerJPRN-jRCTs032180154Karasawa Kumiko30
Active, not recruiting
Phase 1
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancerD001943Breast cancerJPRN-jRCTs032180153Karasawa Kumiko20
Recruiting
Phase 1
Phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancerBreast cancerJPRN-UMIN000010848ational Institute of Radiological Sciences20
Active, not recruiting
Phase 1
A study to investigate the effect of addition of metformin to standard treatment in patients with inoperable stage III non-small cell lung cancer.EUCTR2017-004877-15-BEAntwerp University Hospital, Department Thoracic Oncology104